Insider Actions for Jasper Therapeutics Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 03/21/2022 |
William Lis See Remarks; Director |
89,972 | Award at $0 per share. | 0 |
| 09/24/2021 |
Metalmark Capital LLC |
2,300,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 09/24/2021 |
Metalmark Capital LLC |
2,300,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 09/24/2021 |
Metalmark Capital LLC |
2,300,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 09/24/2021 |
Metalmark Capital LLC |
2,300,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/23/2021 |
Glazer Capital LLC |
151,719 | Disposition at $9.92 per share. | 1,505,052 |
| 04/21/2021 |
Glazer Capital LLC |
1,164 | Disposition at $9.92 per share. | 11,546 |
| 04/19/2021 |
Glazer Capital LLC |
2,060 | Disposition at $9.97 per share. | 20,538 |
| 02/22/2021 |
Glazer Capital LLC |
698 | Disposition at $10.5 per share. | 7,329 |
| 02/19/2021 |
Glazer Capital LLC |
2,112 | Disposition at $10.5 per share. | 22,176 |
| 02/18/2021 |
Glazer Capital LLC |
10,000 | Disposition at $10.45 per share. | 104,500 |
| 02/05/2021 |
Glazer Capital LLC |
212 | Disposition at $10.4 per share. | 2,204 |
| 01/14/2021 |
Glazer Capital LLC |
101 | Disposition at $10.4 per share. | 1,050 |
